Efficacy ProfileAt least as effective as standard of care (enoxaparin + warfarin)
Safety ProfileLower rates of major bleeding vs standard of care (enoxaparin + warfarin)2
DosingA single-agent treatment approach that eliminates the need for bridging
EINSTEIN Clinical TrialsThe largest DVT and PE phase 3 clinical trial program ever conducted (N=9477)
*Among Factor Xa inhibitors and direct thrombin inhibitors.
DVT = deep vein thrombosis; PE = pulmonary embolism.